Literature DB >> 1683705

Intramolecular crosslinking of monomeric fibrinogen by tissue transglutaminase.

S N Murthy1, J Wilson, S L Guy, L Lorand.   

Abstract

In addition to generating polymeric products from human fibrinogen, human erythrocyte transglutaminase (protein-glutamine:amine gamma-glutamyltransferase, EC 2.3.2.13) was shown to catalyze the intramolecular reaction of crosslinking two of the constituent chains within monomeric fibrinogen itself. This internally fused protein derivative contains appreciable amounts of the N epsilon-(gamma-glutamyl)lysine bridge peptide and displays the A alpha.gamma hybrid chain pattern of crosslinking, characteristic for the actions of tissue transglutaminases on fibrinogen. Diagnostic analysis in pathological situations, where such enzymes might have escaped from cells into the plasma environment, should include a search for the internally crosslinked soluble fibrinogen monomer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1683705      PMCID: PMC52977          DOI: 10.1073/pnas.88.23.10601

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Beta-endorphin modification by transglutaminase in vitro: identification by FAB/MS of glutamine-11 and lysine-29 as acyl donor and acceptor sites.

Authors:  P Pucci; A Malorni; G Marino; S Metafora; C Esposito; R Porta
Journal:  Biochem Biophys Res Commun       Date:  1988-07-29       Impact factor: 3.575

2.  Identification of transglutaminase substrates in inside-out vesicles from human erythrocytes: immunoblotting with anti-dansyl antibody.

Authors:  L Lorand; S N Murthy; P T Velasco; F Karush
Journal:  Biochem Biophys Res Commun       Date:  1986-01-29       Impact factor: 3.575

3.  Immunoelectrophoretic characterizations of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. Identification of a rapid mode of hybrid alpha-/gamma-chain cross-linking that is promoted by the gamma-chain cross-linking.

Authors:  J R Shainoff; D A Urbanic; P M DiBello
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

4.  Electron microscopic studies of fibrinogen structure: historical perspectives and recent experiments.

Authors:  H S Slayter
Journal:  Ann N Y Acad Sci       Date:  1983-06-27       Impact factor: 5.691

5.  Analysis of human fibrinogen by scanning transmission electron microscopy.

Authors:  J Wall; J Hainfeld; R H Haschemeyer; M W Mosesson
Journal:  Ann N Y Acad Sci       Date:  1983-06-27       Impact factor: 5.691

6.  New approaches to old problems in the clotting of fibrinogen.

Authors:  L Lorand
Journal:  Ann N Y Acad Sci       Date:  1983-06-27       Impact factor: 5.691

7.  Covalent structure of fibrinogen.

Authors:  A Henschen; F Lottspeich; M Kehl; C Southan
Journal:  Ann N Y Acad Sci       Date:  1983-06-27       Impact factor: 5.691

8.  Morphology of fibrinogen monomers and of fibrin protofibrils.

Authors:  R C Williams
Journal:  Ann N Y Acad Sci       Date:  1983-06-27       Impact factor: 5.691

9.  Activation of transglutaminase during embryonic development.

Authors:  L Cariello; J Wilson; L Lorand
Journal:  Biochemistry       Date:  1984-12-18       Impact factor: 3.162

10.  gamma-Glutamylamine cyclotransferase: specificity toward epsilon-(L-gamma-glutamyl)-L-lysine and related compounds.

Authors:  M L Fink; S I Chung; J E Folk
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

View more
  13 in total

1.  Transglutaminase-catalyzed crosslinking of the Aalpha and gamma constituent chains in fibrinogen.

Authors:  S N Murthy; J H Wilson; T J Lukas; Y Veklich; J W Weisel; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Factor XIII Val34Leu polymorphism and gamma-chain cross-linking at the site of microvascular injury in healthy and coumadin-treated subjects.

Authors:  A Undas; B Brzezinska-Kolarz; K Brummel-Ziedins; J Musial; A Szczeklik; K G Mann
Journal:  J Thromb Haemost       Date:  2005-09       Impact factor: 5.824

3.  Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA.

Authors:  Brian R Hoffmann; Douglas S Annis; Deane F Mosher
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

4.  Mitochondrial aconitase is a transglutaminase 2 substrate: transglutamination is a probable mechanism contributing to high-molecular-weight aggregates of aconitase and loss of aconitase activity in Huntington disease brain.

Authors:  Soo-Youl Kim; Lyuben Marekov; Parvesh Bubber; Susan E Browne; Irina Stavrovskaya; Jongmin Lee; Peter M Steinert; John P Blass; M Flint Beal; Gary E Gibson; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

5.  Neurodegenerative diseases and transglutaminase.

Authors:  L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

6.  Affinity of human erythrocyte transglutaminase for a 42-kDa gelatin-binding fragment of human plasma fibronectin.

Authors:  J T Radek; J M Jeong; S N Murthy; K C Ingham; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

7.  Cross-linking by tissue transglutaminase-2 alters fibrinogen-directed macrophage proinflammatory activity.

Authors:  Lauren G Poole; Anna K Kopec; Matthew J Flick; James P Luyendyk
Journal:  J Thromb Haemost       Date:  2022-02-27       Impact factor: 16.036

8.  Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes.

Authors:  A M Walker; D W Montgomery; S Saraiya; T W Ho; H S Garewal; J Wilson; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

9.  Transglutaminase activation in neurodegenerative diseases.

Authors:  Thomas M Jeitner; Nancy A Muma; Kevin P Battaile; Arthur Jl Cooper
Journal:  Future Neurol       Date:  2009-07-01

10.  Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis.

Authors:  N J Mutch; J S Koikkalainen; S R Fraser; K M Duthie; M Griffin; J Mitchell; H G Watson; N A Booth
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.